Skip to main content

Table 6 Multivariate regression analyses of death odds for HIV inpatients by age, sex, LOS, and comorbidities

From: HIV disease burden, cost, and length of stay in Portuguese hospitals from 2000 to 2010: a cross-sectional study

Independent variables

N (% dead)

OR unadjusted

95% C.I.

OR adjusted

95% C.I.

Age groups - years of age

     

1 - 0 to 17

1,057 (2.9)

1

 

1

 

2 - 18 to 45

40,635 (13.3)

5.068

(3.541–7.253)

4.318

(2.980–6.257)

3 - 46 to 65

12,803 (17.1)

6.837

(4.769–9.802)

5.556

(3.826–8.069)

4 - 66 and older

2,544 (22.9)

9.840

(6.803–4.232)

7.955

(5.424–11.669)

Sex

     

Female

15,210 (11)

1

 

1

 

Male

41,834 (15.6)

1.500

(1.417–1.589)

1.407

(1.326–1.494)

LOS median (alive/deceased)

11.0 / 12.0

1.005

(1.005–1.006)

1.004

(1.003–1.005)

Elixhauser comorbidity measures

     

No comorbidity*

16,850 (9.7)

1

 

1

 

Metastatic cancer

537 (41.5)

4.319

(3.632–5.136)

3.286

(2.732–3.952)

Weight loss

3,753 (30.8)

2.917

(2.710–3.140)

2.501

(2.312–2.704)

Fluid and electrolyte disorders

5,189 (29.9)

2.897

(2.715–3.091)

2.332

(2.176–2.499)

Lymphoma

1,471 (27.5)

2.319

(2.063–2.607)

2.260

(2.000–2.553)

Pulmonary circulation disorders

414 (22.9)

1.782

(1.416–2.244)

2.132

(1.651–2.754)

Cardiac arrhythmias

877 (31.1)

2.749

(2.379–3.178)

2.030

(1.734–2.375)

Solid tumor without metastasis

2,905 (24.1)

1.973

(1.806–2.156)

1.706

(1.552–1.876)

Coagulopathy

3,187 (23.8)

1.953

(1.794–2.126)

1.668

(1.524–1.825)

Blood loss and anemia

1,943 (22.6)

1.780

(1.596–1.985)

1.573

(1.403–1.764)

Peripheral vascular disorders

230 (23.9)

1.877

(1.385–2.544)

1.416

(1.025–1.956)

Congestive heart failure

1,029 (22.6)

1.765

(1.522–2.046)

1.403

(1.195–1.648)

Other neurological disorders

3,329 (20.2)

1.551

(1.420–1.694)

1.364

(1.242–1.498)

Paralysis

708 (21.6)

1.654

(1.380–1.981)

1.331

(1.097–1.614)

Renal failure

1,929 (18.9)

1.403

(1.248–1.576)

1.221

(1.080–1.381)

Peptic ulcer disease excluding bleeding

205 (20.5)

1.537

(1.094–2.159)

1.208

(0.843–1.733)

Alcohol abuse

4,578 (18.1)

1.348

(1.245–1.459)

1.151

(1.057–1.253)

Liver disease

13,905 (15.2)

1.087

(1.030–1.147)

1.027

(0.969–1.088)

Hypertension, uncomplicated

2,191 (12.7)

0.861

(0.757–0.978)

0.685

(0.597–0.785)

Chronic pulmonary disease

2,458 (11)

0.726

(0.638–0.825)

0.542

(0.470–0.625)

Depression

1,597 (9.8)

0.642

(0.544–0.759)

0.533

(0.447–0.635)

Nutrient-deficiency anemia

1,889 (10.7)

0.706

(0.609–0.818)

0.531

(0.455–0.621)

Obesity

225 (7.1)

0.455

(0.273–0.757)

0.474

(0.281–0.799)

  1. *Patients with each comorbidity were compared with patients without that comorbidity. Some Elixhauser comorbidities had no influence on the nonadjusted model and were not included in the analysis, namely rheumatoid arthritis/collagen vascular diseases, psychoses, drug abuse, valvular heart disease, diabetes (both uncomplicated and complicated), complicated hypertension, and hypothyroidism.
  2. LOS = length of hospital stay; OR = odds ratio; 95% CI = 95% confidence interval.